reference/26435079

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26435079

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	440
issn	2397-9070
issueIdentifier	3
pageRange	433-440
publicationName	JGH open : an open access journal of gastroenterology and hepatology
startingPage	433
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6f74b7cda00f6e1592010ae8280dc7d0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a00fabcde302d63a76ef3eae515fd4ec http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf951ea7df022602bb52ee3f06eddf19 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2f59178ef0130ce488e362a206df02b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1f5cd234d1361ecf397e813a5b48dea3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_440cc494924d43097075db65ef2a4823 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e97fd1097af5fbd0a41506c830ef0f26
bibliographicCitation	Marjot T, Green CJ, Charlton CA, Cornfield T, Hazlehurst J, Moolla A, White S, Francis J, Neubauer S, Cobbold JF, Hodson L, Tomlinson JW. Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. JGH Open. 2020 Jun;4(3):433–40. PMID: 32514450; PMCID: PMC7273735.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6542-6323 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8683ea1b5fc6bdd22a964b1470b2e40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39af6465ea0a887a3aadd025590582e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_296945da708f501e91a3dfab21ca74a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b8f7366010ebacd34830f5d37750c48 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9262f9eb4311b0a8d341ed0c8cf1c6b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_010363e147349e12b6abcec0fabcf249 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f40b633e5f4eae61befbefbba5c94980 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7eeb9ee70a177452b76d6e7b6be2fa0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faf6ef10e8027d85c163d52d0d769b27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6933055239747a3a41d17754e612f1f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_422159a56430d681e8969b3febd67139
date	2019-11-05^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32514450 https://doi.org/10.1002/jgh3.12274 https://pubmed.ncbi.nlm.nih.gov/PMC7273735
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/47861 https://portal.issn.org/resource/ISSN/2397-9070
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Sodium‐glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin‐resistant patients without type 2 diabetes
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11475 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887712 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95245167042cebb599d71e1a81bf6d4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7708 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10897 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179

Showing number of triples: 1 to 50 of 50.